Will we survive the year?

anonymous

Guest
Mismanagement, lack of PR's, and just general lack of enthusiasm by JT has put this company in a scary predicament. With reps out of the field, script growth will flatten/drop. Do you guys think we can survive the year? Took a look at the share price today and shut my computer. Its getting ugly out there.
 






Mismanagement, lack of PR's, and just general lack of enthusiasm by JT has put this company in a scary predicament. With reps out of the field, script growth will flatten/drop. Do you guys think we can survive the year? Took a look at the share price today and shut my computer. Its getting ugly out there.

Lack of enthusiasm? You sound like a day trader. But assuming you are not, keep this in mind. Things are getting out of hand everywhere. Just have to hunker down and hope that precautions being taken today make this all pass as fast as possible. Sales will flatten not just because reps are out of the field but also bc patients will stay away from doctors offices for those traditional check ups where vascepa is offered. Not all patients but alot will. Also, not just because reps are out of the field, offices aren't even trying to see us of we were in the field. Lack of PRs? Nothing to report until ACC or until the patent ruling, so what else do you want? Mismanagement? Maybe. But I'm curious in what way? If you are pointing to mismanagement of this covid 19 stuff then I would say most companies are scrambling to enact protocol to maintain business operations right now. This is a situation no one has dealt with. Mismanagement is expected.
 






Definitely shouldn’t have done that expansion. Not that there was anyway to know this was coming, but there are several territories that I know of that are too small to justify 2 reps
 






Lack of enthusiasm? You sound like a day trader. But assuming you are not, keep this in mind. Things are getting out of hand everywhere. Just have to hunker down and hope that precautions being taken today make this all pass as fast as possible. Sales will flatten not just because reps are out of the field but also bc patients will stay away from doctors offices for those traditional check ups where vascepa is offered. Not all patients but alot will. Also, not just because reps are out of the field, offices aren't even trying to see us of we were in the field. Lack of PRs? Nothing to report until ACC or until the patent ruling, so what else do you want? Mismanagement? Maybe. But I'm curious in what way? If you are pointing to mismanagement of this covid 19 stuff then I would say most companies are scrambling to enact protocol to maintain business operations right now. This is a situation no one has dealt with. Mismanagement is expected.
We will survive. Good product that will grow. Hope the scripts do go down, it validates our worth. Chill out, give it a few months, and... wash your hands.
 












Some will survive. Some probably won't if this event is prolonged.

You are aware Amarin reps got laid off after the launch didnt get the anchor population, right? Well, if this event has a near term effect on business, theyll lay off again and ramp back up with other reps down the road.....just like before!
 












Definitely shouldn’t have done that expansion. Not that there was anyway to know this was coming, but there are several territories that I know of that are too small to justify 2 reps



Expansion to this extent was a bad decision. Heads should roll. Do your research. 1 rep per territory was plenty.
 






























I agree...I’m kind of nervous of the Generic Trial results. Are you guys?
giphy.gif
 






With no reps. driving they will pay less in mileage this month, no in clinic lunches, no speaker programs etc.. no overnight hotel says, and no meals for overnight status....that should save us some expenses.